WallStreetZenWallStreetZen

NASDAQ: PTCT
Ptc Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for PTCT

Based on 14 analysts offering 12 month price targets for Ptc Therapeutics Inc

Min Forecast
$50.00-33.86%
Avg Forecast
$81.43+7.71%
Max Forecast
$119.00+57.41%

Should I buy or sell PTCT stock?

Based on 14 analysts offering ratings for Ptc Therapeutics Inc.

Buy
Strong Buy
9 analysts 64.29%
Buy
0 analysts 0%
Hold
4 analysts 28.57%
Sell
0 analysts 0%
Strong Sell
1 analysts 7.14%
Our proven Zen Rating quant model agrees with analyst consensus with a "Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their PTCT stock forecasts and price targets.

PTCT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-01-28Find Out Why
lockedlocked$00.00+00.00%2025-12-01
lockedlocked$00.00+00.00%2025-11-06
lockedlocked$00.00+00.00%2025-11-05
lockedlocked$00.00+00.00%2025-11-05
Goldman Sachs
Bottom 13%
13
Strong SellMaintains$50.00-33.86%2025-11-05
Wells Fargo
Top 33%
68
Strong BuyMaintains$93.00+23.02%2025-11-05
Jefferies
Top 19%
82
Strong BuyMaintains$77.00+1.85%2025-10-28
Cantor Fitzgerald
Top 3%
98
Strong BuyReiterates$118.00+56.08%2025-09-03
Wells Fargo
Top 14%
87
Strong BuyMaintains$73.00-3.44%2025-08-20

1 of 2

Forecast return on equity

Is PTCT forecast to generate an efficient return?

Company
-281.29%
Industry
355.57%
Market
202.3%
PTCT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PTCT forecast to generate an efficient return on assets?

Company
16.57%
Industry
123.33%
PTCT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PTCT earnings per share forecast

What is PTCT's earnings per share in the next 3 years based on estimates from 17 analysts?

Avg 1 year Forecast
-$1.41-114.62%
Avg 2 year Forecast
$1.24-87.11%
Avg 3 year Forecast
$4.30-55.21%
PTCT's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

PTCT revenue forecast

What is PTCT's revenue in the next 3 years based on estimates from 17 analysts?

Avg 1 year Forecast
$961.5M-45.96%
Avg 2 year Forecast
$1.2B-31.2%
Avg 3 year Forecast
$1.5B-13.16%
PTCT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PTCT earnings growth forecast

How is PTCT forecast to perform vs Biotechnology companies and vs the US market?

Company
-24.45%
Industry
70.53%
Market
39.49%
PTCT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
PTCT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
PTCT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

PTCT revenue growth forecast

How is PTCT forecast to perform vs Biotechnology companies and vs the US market?

Company
-4.93%
Industry
116.52%
Market
23.59%
PTCT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PTCT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PTCT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PTCT$75.60$81.43+7.71%Buy
IBRX$6.15$11.80+91.87%Strong Buy
COGT$38.36$40.50+5.58%Buy
PCVX$51.37$77.67+51.19%Buy
GPCR$89.05$110.44+24.02%Strong Buy
View Top Biotech Stocks

Ptc Therapeutics Stock Forecast FAQ

Is Ptc Therapeutics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 14 Wall Street analysts covering (NASDAQ: PTCT) stock is to Buy PTCT stock.

Out of 14 analysts, 9 (64.29%) are recommending PTCT as a Strong Buy, 0 (0%) are recommending PTCT as a Buy, 4 (28.57%) are recommending PTCT as a Hold, 0 (0%) are recommending PTCT as a Sell, and 1 (7.14%) are recommending PTCT as a Strong Sell.

If you're new to stock investing, here's how to buy Ptc Therapeutics stock.

What is PTCT's earnings growth forecast for 2026-2028?

(NASDAQ: PTCT) Ptc Therapeutics's forecast annual earnings growth rate of -24.45% is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 70.53%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.49%.

Ptc Therapeutics's earnings in 2026 is $751,723,000.On average, 17 Wall Street analysts forecast PTCT's earnings for 2026 to be -$112,805,069, with the lowest PTCT earnings forecast at -$517,731,106, and the highest PTCT earnings forecast at $158,489,114. On average, 15 Wall Street analysts forecast PTCT's earnings for 2027 to be $99,453,123, with the lowest PTCT earnings forecast at -$172,868,749, and the highest PTCT earnings forecast at $355,757,479.

In 2028, PTCT is forecast to generate $345,592,980 in earnings, with the lowest earnings forecast at $160,512,379 and the highest earnings forecast at $624,683,157.

What is PTCT's revenue growth forecast for 2026-2028?

(NASDAQ: PTCT) Ptc Therapeutics's forecast annual revenue growth rate of -4.93% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 116.52%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.59%.

Ptc Therapeutics's revenue in 2026 is $1,779,150,000.On average, 17 Wall Street analysts forecast PTCT's revenue for 2026 to be $77,198,811,024, with the lowest PTCT revenue forecast at $55,329,882,508, and the highest PTCT revenue forecast at $99,557,498,200. On average, 15 Wall Street analysts forecast PTCT's revenue for 2027 to be $98,272,885,320, with the lowest PTCT revenue forecast at $70,342,189,777, and the highest PTCT revenue forecast at $137,132,424,940.

In 2028, PTCT is forecast to generate $124,045,431,225 in revenue, with the lowest revenue forecast at $72,742,007,213 and the highest revenue forecast at $154,153,545,600.

What is PTCT's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: PTCT) forecast ROA is 16.57%, which is lower than the forecast US Biotechnology industry average of 123.33%.

What is PTCT's Price Target?

According to 14 Wall Street analysts that have issued a 1 year PTCT price target, the average PTCT price target is $81.43, with the highest PTCT stock price forecast at $119.00 and the lowest PTCT stock price forecast at $50.00.

On average, Wall Street analysts predict that Ptc Therapeutics's share price could reach $81.43 by Jan 28, 2027. The average Ptc Therapeutics stock price prediction forecasts a potential upside of 7.71% from the current PTCT share price of $75.60.

What is PTCT's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: PTCT) Ptc Therapeutics's current Earnings Per Share (EPS) is $9.61. On average, analysts forecast that PTCT's EPS will be -$1.41 for 2026, with the lowest EPS forecast at -$6.45, and the highest EPS forecast at $1.97. On average, analysts forecast that PTCT's EPS will be $1.24 for 2027, with the lowest EPS forecast at -$2.15, and the highest EPS forecast at $4.43. In 2028, PTCT's EPS is forecast to hit $4.30 (min: $2.00, max: $7.78).

What is PTCT's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: PTCT) forecast ROE is -281.29%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.